Abstract
High USP1 and replication stress levels driven by EWS::FLI1 transcription factor in EWS are vulnerabilities that can be exploited to improve existing treatment avenues and overcome drug resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have